IL325620A - מעכבי קינאז 1 דמויי-polo - Google Patents
מעכבי קינאז 1 דמויי-poloInfo
- Publication number
- IL325620A IL325620A IL325620A IL32562025A IL325620A IL 325620 A IL325620 A IL 325620A IL 325620 A IL325620 A IL 325620A IL 32562025 A IL32562025 A IL 32562025A IL 325620 A IL325620 A IL 325620A
- Authority
- IL
- Israel
- Prior art keywords
- polo
- kinase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/84—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363524795P | 2023-07-03 | 2023-07-03 | |
| PCT/US2024/036576 WO2025010279A2 (en) | 2023-07-03 | 2024-07-02 | Polo-like kinase 1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL325620A true IL325620A (he) | 2026-02-01 |
Family
ID=94172200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL325620A IL325620A (he) | 2023-07-03 | 2025-12-25 | מעכבי קינאז 1 דמויי-polo |
Country Status (4)
| Country | Link |
|---|---|
| KR (1) | KR20260032604A (he) |
| AU (1) | AU2024290917A1 (he) |
| IL (1) | IL325620A (he) |
| WO (1) | WO2025010279A2 (he) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2651072A1 (en) * | 2006-05-01 | 2007-11-08 | Pfizer Products Inc. | Substituted 2-amino-fused heterocyclic compounds |
| WO2009084695A1 (ja) * | 2007-12-28 | 2009-07-09 | Carna Biosciences Inc. | ２－アミノキナゾリン誘導体 |
| WO2014201173A1 (en) * | 2013-06-12 | 2014-12-18 | Amgen Inc. | Bicyclic sulfonamide compounds as sodium channel inhibitors |
| AU2014308616B2 (en) * | 2013-08-23 | 2018-12-06 | Neupharma, Inc. | Certain chemical entities, compositions, and methods |
| AU2014331794C1 (en) * | 2013-10-10 | 2019-09-12 | Araxes Pharma Llc | Inhibitors of KRAS G12C |
| EP4240363A4 (en) * | 2020-11-09 | 2024-10-23 | Merck Sharp & Dohme LLC | 2-AMINOQUINAZOLINE 7-PHENYL SUBSTITUTED, HPK1 INHIBITORS |
-
2024
- 2024-07-02 AU AU2024290917A patent/AU2024290917A1/en active Pending
- 2024-07-02 WO PCT/US2024/036576 patent/WO2025010279A2/en active Pending
- 2024-07-02 KR KR1020267003417A patent/KR20260032604A/ko active Pending
-
2025
- 2025-12-25 IL IL325620A patent/IL325620A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024290917A1 (en) | 2026-01-22 |
| WO2025010279A2 (en) | 2025-01-09 |
| WO2025010279A3 (en) | 2025-05-01 |
| WO2025010279A9 (en) | 2025-12-18 |
| KR20260032604A (ko) | 2026-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290508A (he) | תרכובות הטרוציקליות כמעכבי קינאז | |
| IL308346A (he) | מעכבי קינאז 4 דמוי polo | |
| ZA202109737B (en) | Compound used as kinase inhibitor and application thereof | |
| PT3956322T (pt) | Inibidor seletivo de cinase jak1 | |
| SMT202400242T1 (it) | Composti triazolopiridinilici come inibitori di chinasi | |
| EP4289847A4 (en) | PIM KINASE INHIBITOR | |
| IL318171A (he) | מעכבי קינאז אמינוהטרואריל | |
| IL314049A (he) | מעכבי parp7 | |
| GB202008201D0 (en) | Inhibitor compounds | |
| IL314397A (he) | מעכבים של cdk4/6 קינאז | |
| IL313548A (he) | מעכבי met קינאז | |
| PT3924351T (pt) | Forma cristalina do sal cloridrato de 2-((1r,4r)-4-((3-(3 (trifluorometil)fenil) imidazo[1,2-b]piridazin-6-il)amino) ciclohexil)propan-2-ol | |
| GB202004960D0 (en) | Inhibitor compounds | |
| EP3915636A4 (en) | HYDRAZIDE COMPOUND AND KINASE INHIBITOR | |
| IL297684B1 (he) | תהליכים להכנת מעכב קינאז | |
| GB202300881D0 (en) | Inhibitor compounds | |
| IL325620A (he) | מעכבי קינאז 1 דמויי-polo | |
| SMT202200227T1 (it) | Composti di 1h-indazol-3-carbossammide come inibitori della glicogeno sintasi chinasi 3 beta | |
| CA3297222A1 (en) | Polo-like kinase 1 inhibitors | |
| IL281599A (he) | מעכבי קינאז tyk2 | |
| IL313412A (he) | תרכובות הטרוציקליות כמערך של נוגדי קינאזות | |
| GB202307924D0 (en) | Inhibitor compounds | |
| IL287963A (he) | תרכובות של מעכב מחליף נתרן-מימן 3 | |
| GB202407631D0 (en) | Kinase | |
| IL326145A (he) | מעכבים של cdk2/4/6 קינאז |